PCR artifacts can explain the reported biallelic JAK2 mutations.

Suppr

超能文献

作者信息

Gao R, Zhao A H, Du Y, Ho W T, Fu X, Zhao Z J

出版信息

Blood Cancer J. 2012 Feb;2(2):e56. doi: 10.1038/bcj.2012.2. Epub 2012 Feb 17.

DOI:10.1038/bcj.2012.2

PMID:22829246

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3288281/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c6f/3288281/27fbd2bc9594/bcj20122f1.jpg

相似文献

PCR artifacts can explain the reported biallelic JAK2 mutations.

Blood Cancer J. 2012 Feb;2(2):e56. doi: 10.1038/bcj.2012.2. Epub 2012 Feb 17.

JAK2 V617F, MPL W515L and JAK2 Exon 12 Mutations in Chinese Patients with Primary Myelofibrosis.

Chin J Cancer Res. 2012 Mar;24(1):72-6. doi: 10.1007/s11670-012-0072-4.

Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line.

Blood. 2005 Mar 15;105(6):2535-42. doi: 10.1182/blood-2004-09-3701. Epub 2004 Nov 30.

[Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in MedB-1 mediastinal lymphoma line].

Verh Dtsch Ges Pathol. 2005;89:234-44.

Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients.

Hematology. 2017 Dec;22(10):599-606. doi: 10.1080/10245332.2017.1312736. Epub 2017 Apr 13.

The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.

Haematologica. 2007 Dec;92(12):1607-14. doi: 10.3324/haematol.11643.

Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms.

Genet Test Mol Biomarkers. 2018 Feb;22(2):98-103. doi: 10.1089/gtmb.2017.0203. Epub 2018 Jan 11.

JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients.

PLoS One. 2011;6(7):e22148. doi: 10.1371/journal.pone.0022148. Epub 2011 Jul 18.

[JAK2 exon 12 mutations in patients with Philadelphia (Ph) chromosome-negative myeloproliferative neoplasms].

Zhonghua Xue Ye Xue Za Zhi. 2012 Sep;33(9):705-9. doi: 10.3760/cma.j.issn.0253-2727.2012.09.004.

A novel JAK2 exon 12 mutation identified in the retrospective analysis of paraffin-embedded tissues of polycythemia vera patients.

Diagn Mol Pathol. 2009 Jun;18(2):108-11. doi: 10.1097/PDM.0b013e318190eed0.

引用本文的文献

Ten simple rules for a successful international consortium in big data omics.

PLoS Comput Biol. 2022 Oct 20;18(10):e1010546. doi: 10.1371/journal.pcbi.1010546. eCollection 2022 Oct.

Transcriptional-Readthrough RNAs Reflect the Phenomenon of "A Gene Contains Gene(s)" or "Gene(s) within a Gene" in the Human Genome, and Thus Are Not Chimeric RNAs.

Genes (Basel). 2018 Jan 16;9(1):40. doi: 10.3390/genes9010040.

Hypothesis: Artifacts, Including Spurious Chimeric RNAs with a Short Homologous Sequence, Caused by Consecutive Reverse Transcriptions and Endogenous Random Primers.

J Cancer. 2015 May 1;6(6):555-67. doi: 10.7150/jca.11997. eCollection 2015.

The role of interruptions in polyQ in the pathology of SCA1.

PLoS Genet. 2013;9(7):e1003648. doi: 10.1371/journal.pgen.1003648. Epub 2013 Jul 25.

本文引用的文献

Independently acquired biallelic JAK2 mutations are present in a minority of patients with essential thrombocythemia.

Blood. 2010 Aug 12;116(6):1013-4. doi: 10.1182/blood-2010-05-284356.

In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm.

Blood. 2009 Oct 1;114(14):3018-23. doi: 10.1182/blood-2009-03-209916. Epub 2009 Jun 18.

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

Nat Genet. 2009 Apr;41(4):450-4. doi: 10.1038/ng.341. Epub 2009 Mar 15.

Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders.

Nat Rev Cancer. 2007 Sep;7(9):673-83. doi: 10.1038/nrc2210.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验